Evidence map›Paper›PMID 42458542›Full record

ArticleBorderline personality disorder and emotion dysregulation2026

Follow-up effects of a brief Good Psychiatric Management treatment for borderline personality disorder.

José Blanco Machinea, Loris Grandjean, Hélène Beuchat, Stéphane Kolly, Philippe Conus, Yves de Roten, Jérémie André, Hervé Tissot, Ueli Kramer

Abstract read
PubMed Publisher
In one paragraph

Article in Borderline personality disorder and emotion dysregulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

José Blanco MachineaDepartment of Psychiatry, University Institute of Psychotherapy, University of Lausanne and Lausanne University Hospital, Route de Cery 1, Prilly-Lausanne, CH-1008, Switzerland. jose.blanco-machinea@chuv.ch.
Loris GrandjeanDepartment of Psychiatry, University Institute of Psychotherapy, University of Lausanne and Lausanne University Hospital, Route de Cery 1, Prilly-Lausanne, CH-1008, Switzerland.
Hélène BeuchatGeneral Psychiatry Service, Department of Psychiatry, Lausanne University Clinic and University of Lausanne, Lausanne, Switzerland.
Stéphane KollyGeneral Psychiatry Service, Department of Psychiatry, Lausanne University Clinic and University of Lausanne, Lausanne, Switzerland.
Philippe ConusGeneral Psychiatry Service, Department of Psychiatry, Lausanne University Clinic and University of Lausanne, Lausanne, Switzerland.
Yves de RotenDepartment of Psychiatry, University Institute of Psychotherapy, University of Lausanne and Lausanne University Hospital, Route de Cery 1, Prilly-Lausanne, CH-1008, Switzerland.
Jérémie AndréGeneral Psychiatry Service, Department of Psychiatry, Lausanne University Clinic and University of Lausanne, Lausanne, Switzerland.
Hervé TissotDepartment of Psychiatry, University Institute of Psychotherapy, University of Lausanne and Lausanne University Hospital, Route de Cery 1, Prilly-Lausanne, CH-1008, Switzerland.
Ueli KramerDepartment of Psychiatry, University Institute of Psychotherapy, University of Lausanne and Lausanne University Hospital, Route de Cery 1, Prilly-Lausanne, CH-1008, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBorderline personality disorder (BPD) is among the most frequent, debilitating, and lethal mental conditions. Treatment for patients with BPD involves structured psychotherapy, but such treatment is often not readily available due to imbalances in supply and demand for care. Brief treatments that are available as first-line interventions may address this delay in care. No controlled study has assessed the effectiveness of brief psychiatric interventions, such as 10 sessions of Good Psychiatric Management (GPM) over 12 months follow-up, in comparison with treatment as usual. Whereas most psychotherapy studies in patients with BPD focus on symptom reduction at the end of treatment, more research is needed on the patients' symptom levels after one year.

methodsThe present study compares brief psychiatric treatment (4 months of GPM) with treatment as usual (4 months of TAU). Participants (N = 76 patients with BPD) undergo assessments at intake, after two months, at discharge (4 months) and 1 year follow-up (16 months after intake). At these four time-points, each patient was assessed using the clinician rated Zanarini BPD (ZAN-BPD) scale.

resultsThe study found brief GPM to show significantly greater symptom reduction in ZAN-BPD scores between intake of 4-month treatment and 12-month follow-up (16 months later), compared to treatment as usual.

conclusionThis study shows that after one year, the effects of a brief psychiatric treatment are strengthened in both groups. Additionally, brief GPM presents an advantage in helping BPD patients make further progress after the intervention has ended, which potentially helps diminish the societal burden of disease related to BPD symptomatology.

Indexed as

Borderline personality disorderFollow-upGood psychiatric managementOutcome research

Identifiers

PMID42458542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.